Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults

Autor: Ali, S.O., Yu, X.Q., Robbie, G.J., Wu, Y., Shoemaker, K., Yu, L., DiGiandomenico, A., Keller, A.E., Anude, C., Hernandez-Illas, M., Bellamy, T., Falloon, J., Dubovsky, F., Jafri, H.S.
Zdroj: In Clinical Microbiology and Infection May 2019 25(5):629-629
Databáze: ScienceDirect